World Whole Genome and Exome Sequencing Market Report 2023-2027: Pathogen Challenges, Diagnostic Factors, Interpreting the Code, Fertility Technology Driving Growth

News provided by

Feb 08, 2023, 19:30 ET

DUBLIN, Feb. 8, 2023 /PRNewswire/ -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.

The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.

Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?

The plummeting costs for Whole Genome Sequencing are creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.

Key Topics Covered:

Market Overview

Market Participants Play Different Roles

Instrument Manufacturer
Independent lab specialized/esoteric
Independent lab national/regional
Independent lab analytical
Public National/regional lab
Hospital lab
Physician lab
DTC Lab
Sequencing Labs
Audit body

Whole Genome Sequencing - Markets, Examples and Discussion

Direct to Consumer - Two Approaches
The New Age of Medical Information
Dangers in DTC-WGS - Health Costs and Regulation
Newborn and Prenatal - A Brave New World
DTC - How Many Segments?
Research Markets
Research Funding and Capital Expense
WGS Datasets Preferred
Existing research repurposed
Organism Wide Market
Service Suppliers Respond
Clinical - Understanding Germline and Somatic
Somatic - Chasing Mutations and Pharmacogenomics
Pathogen Testing
The Hepatitis C Story
Will the Microbiology Department Disappear?
AgriBio - Big Business
GMO is Here to Stay
WGS Benefits and Risks
The New Agriculture

Industry Structure

Hospital's Testing Share
Economies of Scale
Instrument Manufacturer Role
Healthcare Industry Impacts - Still Struggling
Can the Healthcare Industry Adapt?
Genetic Counselling as an Industry
WGES Adoption and Cannibalization
The Meaning of Grail

Market Trends

Factors Driving Growth

Diagnostic Factors
Interpreting the Code Otherwise
Changes in Agriculture
Fertility Technology Comes of Age
Pathogen Challenges

Factors Limiting Growth

Increased Competition Lowers Price
Lower Costs
Healthcare Cost Concerns Curtail Growth
Wellness has a downside
GMO Opposition Movement

Sequencing Instrumentation

Instrumentation Tenacity
Declining Cost Changes Industry Structure
LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS
llumina
ION
Pacific Biosystems
Roche
SOLiD
Oxford Nanopore
What is Oxford Nanopore Sequencing?
What can Oxford Nanopore Sequencing be used for?
Oxford Nanopore Products
Long Reads - Further Segmentation
Linked Reads
Targeted Sequencing Adopts CRISPR
New Sequencing Technologies
RNAP sequencing
In vitro virus high-throughput sequencing
Tunnelling currents DNA sequencing
Sequencing by hybridization
Sequencing with mass spectrometry
Microfluidic Sanger sequencing
Microscopy-based techniques

WGES Recent Developments

Genomics England, Aims to Sequence 100K Newborns
Juno Diagnostics NIPT With At-Home Sample Collection
Cardio Diagnostics Launches Genetic Cardio Risk Test
Universal Genetic Testing in Breast Cancer Further Supported
Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
MyOme Lands Investment for WGS
GenomSys Gains CE Mark for New Genomic Analysis Software
WGS Finds Lung Cancers Fall Into Molecular Subtypes
Testing Distinguishes Benign Tumors From Precancerous Condition
Plan to Sequence All Newborns in UK
Clear Labs Raises $60M for Nanopore Sequencing
Variantyx Expands Into Prenatal, Cancer Testing
Whole-Genome Sequencing Aids Diagnosis in Stockholm
Variantyx Raises $20M
Nonacus WGS Service for SARS-CoV-2 Laboratories
Center to Report Risk Scores in Clinical WGS
Stanford Launches WGS for Cardiovascular Testing
Illumina and NY Healthcare Partner on Clinical WGS
Increased Adoption of WGS Needs Acceptance by Payors, Providers
Veritas Intercontinental Completes €5M Series B Financing Round
M2GEN and Discovery Life Sciences in Bioinformatics Agreement
Genomics England Adopts Quantum ActiveScale Object Storage
GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx
NHS Wales Introduces WGS for Critically Ill Newborns
Illumina Achieves EAU for NGS-Based SARS-CoV-2 Test
C2i Genomics to Launch Trials for MRD Detection Tech
Roche Acquires Sequencing Company Stratos Genomics
UK COVID-19 Sequencing Consortium Launches
Invitae Acquires Three Companies: YouScript, Genelex, Diploid
Experience From Centralized Genomic Medicine Lab
MGI to Enable $100 Human Genome
Nebula Genomics offers $299 WGS
Team to Study Campylobacter Omics
Veritas Genetics Restarts US Business
NEOGEN, Gencove partner to advance animal genomics
UK Whole-Genome Sequencing Project Obtains £200M
WGS may help with disease outbreaks
Veritas Cuts WGS Price by 40%
Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
Machine-learning system used to diagnose genetic diseases
Whole Genome Sequencing for healthy creates controversy
Nebula Genomics Offers FREE Whole Genome Sequencing

Profiles of Key Companies

10x Genomics, Inc
Diagnostics
23andME Inc
Abbott Laboratories
AccuraGen Inc
Adaptive Biotechnologies
Admera Health, LLC
Agilent/Dako
Akonni Biosystems
Amoy Diagnostics Co., Ltd
Ancestry.com LLC
Anchor Dx
ARUP Laboratories
Baylor Miraca Genetics Laboratories
Beckman Coulter Diagnostics
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bioarray Genetics
Biocept, Inc.
Biodesix Inc.
BioFluidica
BioGenex
Biolidics Ltd
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc
Bio-Techne
C2i Genomics
Caris Molecular Diagnostics
CellMax Life
Centogene
Circulogene
Clear Labs
Clinical Genomics
Complete Genomics, Inc. - A BGI Company
Dante Labs
Datar Cancer Genetics Limited
Day Zero Diagnostics.
Diasorin S.p.A
Epic Sciences
Epigenomics AG
Eurofins Scientific
Excellerate Bioscience
Fabric Genomics
Freenome
FUJIFILM Wako Diagnostics
Fujirebio
Fulgent Genetics
GE Global Research
Gencove
Genedrive
GeneFirst Ltd
Genetron Holdings
Genewiz
Genomics England
Genomics Personalized Health (GPH)
GenomOncology
Genzyme Corporation
Grifols
Guardant Health
Guardiome
HeiScreen
Helix
Helomics
Hologic
HTG Molecular Diagnostics
Human Longevity, Inc
iCellate
Illumina
Incell Dx
Inivata
Invitae Corporation
Invivoscribe
Karius
Lunglife AI Inc
Macrogen
MDNA Life SCIENCES, Inc
MDx Health
Medgenome
Meridian Bioscience
Mesa Biotech (Thermo Fisher)
Mesa Laboratories, Inc
miR Scientific
MNG Labs
NantHealth, Inc
Natera
Nebula Genomics
NeoGenomics
New England Biolabs, Inc
Novogene Bioinformatics Technology Co., Ltd
Omega Bioservices
Oncocyte
OncoDNA
OpGen
ORIG3N, Inc
Origene Technologies
Oxford Nanopore Technologies
Panagene
Pathogenomix
Perkin Elmer
Personal Genome Diagnostics
Personalis
Precipio
PrecisionMed
Promega
Protagen Diagnostics
Qiagen
QuantuMDx
Regeneron Pharmaceuticals
Roche Molecular Diagnostics
Roswell Biotechnologies
Seegene
Sequencing.com
Siemens Healthineers
simfo GmbH
Singlera Genomics Inc
SkylineDx
Standard BioTools
Sure Genomics, Inc
Sysmex
Sysmex Inostics
Tempus Labs, Inc
Thermo Fisher Scientific Inc
Variantyx
Volition
Vyant Bio

For more information about this report visit https://www.researchandmarkets.com/r/a4pjsi-genome-and?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets